Answers are grounded in this paper and cite their sources.
// Víctor M. Blanco 1 , Zhengtao Chu 1, 2 , Kathleen LaSance 3 , Brian D. Gray 4 , Koon Yan Pak 4 , Therese Rider 5 , Kenneth D. Greis 5 , Xiaoyang Qi 1, 2 1 Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA 2 Division of Human Genetics, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 45229, USA 3 Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA 4 Molecular Targeting Technologies, Inc., West Chester, Pennsylvania 19380, USA 5 Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA Correspondence to: Xiaoyang Qi, email: xiaoyang.qi@uc.edu Keywords: glioblastoma, liposome, PET, optical imaging, SapC-DOPS Abbreviations: SapC, Saposin C; DOPS, dioleylphosphatidylserine; PS, phosphatidylserine Received: June 25, 2015 Accepted: March 28, 2016 Published: April 16, 2016 ABSTRACT Multimodal tumor imaging with targeted nanoparticles potentially offers both enhanced specificity and sensitivity, leading to more precise cancer diagnosis and monitoring. We describe the synthesis and characterization of phenol-substituted, lipophilic orange and far-red fluorescent dyes and a simple radioiodination procedure to generate a dual (optical and nuclear) imaging probe. MALDI-ToF analyses revealed high iodination efficiency of the lipophilic reporters, achieved by electrophilic aromatic substitution using the chloramide 1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril (Iodogen) as the oxidizing agent in an organic/aqueous co-solvent mixture. Upon conjugation of iodine-127 or iodine-124-labeled reporters to tumor-targeting SapC-DOPS nanovesicles, optical (fluorescent) and PET imaging was performed in mice bearing intracranial glioblastomas. In addition, tumor vs non-tumor (normal brain) uptake was compared using iodine-125. These data provide proof-of-principle for the potential value of SapC-DOPS for multimodal imaging of glioblastoma, the most aggressive primary brain tumor.
No takes yet. Share an insight, caveat, or question.
Blanco et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: